Diabetes:TNF-α具有类胰岛素样作用

2013-07-24 Diabetes dxy

TNF-α注射对血糖动静脉差异的影响 TNF-α具有广泛的代谢作用。然而,系统性TNF-α治疗产生复杂的激素和代谢效应。为了验证局部、安慰剂对照TNF-α输注是否能直接影响胰岛素抵抗和蛋白质分解。来自丹麦奥胡斯大学的Ermina Bach教授及其团队进行了一项研究,该研究发现TNF-α具有类胰岛素样作用。该研究结果在线发表在2013年7月8日的《糖尿病》(Diabetes)杂志上


TNF-α注射对血糖动静脉差异的影响

TNF-α具有广泛的代谢作用。然而,系统性TNF-α治疗产生复杂的激素和代谢效应。为了验证局部、安慰剂对照TNF-α输注是否能直接影响胰岛素抵抗和蛋白质分解。来自丹麦奥胡斯大学的Ermina Bach教授及其团队进行了一项研究,该研究发现TNF-α具有类胰岛素样作用。该研究结果在线发表在2013年7月8日的《糖尿病》(Diabetes)杂志上。

该研究在3小时基础期和3小时高胰岛素正常血糖钳夹试验期研究8例有双侧股静脉和股动脉导管的健康受试者。受试者一侧动脉输注生理盐水,另一次输注TNF-α。

该研究结果表明,在钳夹试验期间,TNF-α输注增加血糖有动静脉差异(0.91±0.17mmol/l vs 0.74±0.15mmol/l,p=0.012),并增加下肢葡萄糖摄取率。TNF-α输注后净苯丙氨酸释放增加,伴随显现率和消失率增加。游离脂肪酸动力学没有受到TNF-α影响,然而IL-6释放增加。肌肉活检组织的胰岛素和蛋白质信号没有受到TNF-α影响。TNF-α直接增加净肌肉蛋白丢失,在危重疾病期间可导致总蛋白丢失和恶病质。该研究发现的胰岛素敏感性增加可能与IL-6有关,具有重要的临床意义,并可以同时起到提供充足的组织能量供应和导致系统性低血糖发生。

该研究发现,这种独特的代谢特征使TNF-α成为少数人类来源胰岛素类似物中的一种。


Ermina Bach, Roni R. Nielsen, Mikkel H. Vendelbo, Andreas B. Møller, Niels Jessen, Mads Buhl, Thomas K. Hafstrøm, Lars Holm, Steen B. Pedersen, Henriette Pilegaard, Rasmus S. Biensø, Jens O. L. Jørgensen, and Niels Møller Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo controlled bilaterally infused human leg; increased insulin sensitivity, increased net protein breakdown and increased IL-6 release. Diabetes published ahead of print July 8, 2013

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
    2014-04-24 baoya
  2. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1749425, encodeId=0cb11e49425e8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Thu Apr 24 05:23:00 CST 2014, time=2014-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901130, encodeId=3e9b1901130e9, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jan 13 19:23:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636721, encodeId=72711636e2179, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Dec 27 10:23:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809811, encodeId=d88f18098110a, content=<a href='/topic/show?id=04878388e33' target=_blank style='color:#2F92EE;'>#胰岛素样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83887, encryptionId=04878388e33, topicName=胰岛素样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Tue Mar 25 20:23:00 CST 2014, time=2014-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759327, encodeId=b70f1e59327e7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Aug 31 07:23:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401616, encodeId=184e140161699, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Fri Jul 26 08:23:00 CST 2013, time=2013-07-26, status=1, ipAttribution=)]
    2013-07-26 snowpeakxu

相关资讯

Diabetes Care:胰岛素自身抗体水平有助提高T1D风险预测

为了评价将多个胰岛素自身抗体水平添加到糖尿病危险评分中是否可提高1型糖尿病(T1D)风险预测。来自佛罗里达迈阿密大学内分泌科的Sosenko博士等人进行了一项研究,研究发现,自身抗体水平在评估T1D风险中具有重要的作用。多个抗体水平可添加到能准确预测T1D风险的ABRS中。研究结果在线发表于2013年7月1日美国的《糖尿病治疗》(Diabetes Care)杂志上。 研究对象为784名“

ADA 2013:纪立农认为ORBIT研究示中国T2DM患者胰岛素治疗不及时

    2013年第73届美国糖尿病协会科学年会(ADA2013)于6月21日~25日在美国芝加哥隆重举办,在ADA2013年会上,北京大学第一医院纪立农教授有5篇中国研究入选壁报讨论(2篇 General Poster Sessions)和会议摘要(3篇 Published Only)。其中一篇会议摘要题目为“中国ORBIT研究的设计及9760位患者的基线资料:在真

science daily :哺乳期产奶不足或与胰岛素失调有关

      胰岛素在母乳生产中扮演了重要的角色。最新的研究可以解释为什么许多母亲难以生产足够的母乳喂养她们的宝宝。研究人员描述了胰岛腺体如何在哺乳期母乳生产方面变得高度敏感以及特定基因在哺乳期是如何切换的。 产奶难与胰岛素有关 辛辛那提儿童医院医学中心的一位科学家劳里.罗蒙森-里弗斯表示,有关母乳生产时乳腺的情况,利用核糖酸测序技术可以显示“精致细节 ”的蓝图。这些研究结果于7月

BMC Public Health:纪立农等发现中国2型糖尿病患者达标率低

入组患者基线特征 中国成人中2型糖尿病(T2DM)的患病率增长迅速,但现有中国糖尿病管理和血糖控制状况的数据有限。为了评估口服降糖药(OADs)、胰高血糖素样肽-1(GLP-1)受体激动剂和胰岛素在中国多地区T2DM治疗中的疗效。来自北京大学纪立农教授及其团队进行了一项研究(Glycemic control among patients in China with type 2

ADA 2013:ORIGIN研究揭示甘精胰岛素和二甲双胍不改变癌症发生风险

几项对理赔数据库的回顾性分析发现,胰岛素使用与癌症发生(CA)有关,二甲双胍可减少癌症发生。Louise Bordeleau博士在美国糖尿病学会2013年会上介绍了ORIGIN的研究结果,发现二甲双胍和甘精胰岛素对受试者的CA风险没有影响。 ORIGIN研究是一项国际性双盲随机2*2析因试验,对比在心血管(CV)风险较高的糖尿病前期或糖尿病(DM)患者中,甘精胰岛素(来得时)或标准治疗与omeg

Diabetes Care:闭环胰岛素给药系统有益于预防T1DM患者夜间低血糖风险

1型糖尿病患者午后运动增加夜间低血糖(NH)风险。来自康涅狄格州耶鲁大学医学院儿科的Sherr博士等人进行了一项研究,研究假设:无论之前有或没有午后运动,在预防NH和维持夜间目标血糖范围内较高比例的血糖水平上,自动反馈控制的闭环(CL)胰岛素给药系统优于开环(OL)给药系统。研究发现,无论午后的活动水平如何,CL胰岛素给药系统是一种有效的降低NH风险的方法,同时增加血糖值在目标范围内的比例。研究结